These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3532456)

  • 21. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients.
    Katz SM; Kimball PM; Ozaki C; Monsour H; Clark J; Cavazos D; Kahan BD; Wood RP; Kerman RH
    Transplantation; 1994 Feb; 57(4):616-20. PubMed ID: 8116049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab.
    Beimler JH; Morath C; Schmidt J; Ovens J; Opelz G; Rahmel A; Zeier M; Süsal C
    Transplantation; 2009 Mar; 87(5):668-71. PubMed ID: 19295310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [HLA cytotoxins--the cause of positive indirect antiglobulin and LISS tests in pretransfusion examinations].
    Májský A; Korínková P; Kubícková Z
    Cas Lek Cesk; 1985 Mar; 124(12):364-7. PubMed ID: 3873992
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
    Won DI; Jeong HD; Kim YL; Suh JS
    Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful renal allografts in recipients with a positive standard, DTE negative cross-match.
    Barger BO; Shroyer TW; Hudson SL; Deierhoi MH; Barber WH; Curtis JJ; Julian BA; Luke RG; Diethelm AG
    Transplant Proc; 1989 Feb; 21(1 Pt 1):746-7. PubMed ID: 2650253
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of the antiglobulin versus extended incubation time crossmatch: results in 223 renal transplants.
    Cross DE; Whittier FC; Weaver P; Foxworth J
    Transplant Proc; 1977 Dec; 9(4):1803-6. PubMed ID: 341439
    [No Abstract]   [Full Text] [Related]  

  • 28. Perioperative cyclosporine: interaction with multifactorial variables and effect on allograft function.
    Mendez R; Koussa N; Alanizi A; Mendez RG; Iwaki Y; Bogaard TP; Khetan U
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):12-5. PubMed ID: 3515677
    [No Abstract]   [Full Text] [Related]  

  • 29. Prediction of negative crossmatch: an aid for cost-effective kidney sharing.
    Mickey MR; Ayoub G; Terasaki PI
    Transplant Proc; 1982 Jun; 14(2):279-81. PubMed ID: 6810521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [HLA-compatibility testing in kidney transplantation--past, present and future].
    van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Lansbergen Q; Cohen B
    Chirurg; 1980 May; 51(5):257-62. PubMed ID: 6447582
    [No Abstract]   [Full Text] [Related]  

  • 31. Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.
    Delgado JC; Eckels DD
    Exp Mol Pathol; 2008 Aug; 85(1):59-63. PubMed ID: 18499103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrasting results of immunological monitoring in cyclosporine- and azathioprine-treated renal allograft recipients.
    Waltzer WC; Arnold AN; Anaise D; Rapaport FT
    Transplant Proc; 1986 Aug; 18(4):970-3. PubMed ID: 3526668
    [No Abstract]   [Full Text] [Related]  

  • 33. SEOPF high-grade match algorithm: the effect of HLA matching with ROP trays in transplanting highly sensitized patients. Southern Organ Procurement Foundation.
    Tardif GN; McCalmon RT
    Clin Transplant; 1996 Dec; 10(6 Pt 2):594-7. PubMed ID: 8996748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of immunological parameters in kidney transplantation.
    Kreisler JM
    Proc Eur Dial Transplant Assoc; 1983; 19():407-23. PubMed ID: 6348742
    [No Abstract]   [Full Text] [Related]  

  • 35. [Relation of the effect of human complement in the cytotoxic test to the origin of the HLA serum].
    Májský A
    Vnitr Lek; 1989 Nov; 35(11):1102-5. PubMed ID: 2483006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients.
    Kreijveld E; Hilbrands LB; van Berkel Y; Joosten I; Allebes W
    Transplantation; 2007 Nov; 84(9):1092-6. PubMed ID: 17998862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
    Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG
    Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
    [No Abstract]   [Full Text] [Related]  

  • 38. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team.
    Martin S; Connolly J; Jos V
    Transplant Proc; 1993 Feb; 25(1 Pt 1):265-6. PubMed ID: 8438295
    [No Abstract]   [Full Text] [Related]  

  • 39. Detrimental effect of a positive B lymphocyte crossmatch in renal transplantation.
    Russ GR; Nicholls C; Sheldon A; Hay J
    Transplant Proc; 1987 Apr; 19(2):2837-9. PubMed ID: 3551222
    [No Abstract]   [Full Text] [Related]  

  • 40. HLA-DR matching is effective in reducing posttransplant costs in renal allograft recipients on triple therapy.
    Taylor CJ; Bayne AM; Welsh KI; Morris PJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):210-1. PubMed ID: 8438273
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.